Skip to main content

Security report for sicor.lt

Teva · Healthcare · Lithuania

Medium risk. 6 critical or high findings in GDPR outside view, Security headers and 1 other check.

Security score

71/100

Risk levelMedium

0–100, higher is better. How it is calculated

Teva Lithuania operates as a regional branch of the global pharmaceutical company Teva Pharmaceutical Industries, providing a wide range of generic and specialty medicines. The website serves as a corporate and informational platform targeting patients, healthcare professionals, and caregivers in Lithuania. It emphasizes patient safety, social responsibility, and product quality. The digital infrastructure employs modern JavaScript libraries and analytics tools such as Microsoft Clarity and Application Insights, alongside a cookie consent mechanism ensuring GDPR compliance. Security posture is solid with HTTPS enforced and no visible vulnerabilities, though explicit security headers and incident response information are absent. The domain WHOIS data is unavailable due to query limits, but the website's branding and external links strongly indicate legitimacy. Overall, the site is professional, well-structured, and compliant with privacy regulations, supporting Teva's market position in healthcare.

Scanned

NIS2 and GDPR posture

GDPR outside view
33/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching sicor.lt

This scan found 17 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
65
Security headers
55
Email security
88
DNS health
85
Network security
100
GDPR outside view
33
Average
71

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention sicor.lt, from OffSeq Breach.

No leaked records found

Breach holds no records for sicor.lt right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company is positioned as a major player in the pharmaceutical sector, focusing on accessibility and innovation in medicines. Its business model centers on manufacturing and distributing generic and specialty drugs, targeting both patients and healthcare providers. The website content and linked domains reflect a strong partnership ecosystem including social media and career portals. The absence of direct contact details on the site suggests a focus on corporate communication channels elsewhere. The site supports brand trust through consistent messaging and comprehensive policy disclosures, indicating a mature digital presence aligned with corporate governance standards.

Security posture

The website demonstrates a good security baseline with HTTPS and cookie consent mechanisms in place. However, it lacks explicit security headers such as Content Security Policy (CSP), HSTS, and X-Frame-Options, which could enhance protection against common web attacks. No incident response or vulnerability disclosure information is published, which is a gap in transparency and readiness. No sensitive data exposure or vulnerable libraries were detected in the HTML content. The use of reputable analytics and monitoring services is balanced with privacy compliance. Overall, the security posture is adequate but could be improved with additional headers and published security policies.

Recommendations

  1. Implement and enforce security headers including CSP, HSTS, and X-Frame-Options to strengthen web security.
  2. Publish a dedicated security policy and incident response page to improve transparency and preparedness.
  3. Provide clear contact channels for security incidents, such as a security@ email address.
  4. Consider adding a vulnerability disclosure program or security.txt file to encourage responsible reporting.
  5. Regularly audit third-party scripts and analytics tools to ensure ongoing privacy compliance and security.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Teva
Description
Teva Lithuania is a pharmaceutical company providing innovative and high-quality medicines to millions of people worldwide. The website highlights their commitment to patient health, social impact, and product quality.
Key services
Generic medicines, Specialty medicines, Patient safety information, Health awareness and education
Content quality
good
Branding
consistent

Technology

Stack
jQuery 3.5.1, jQuery UI 1.13.2, Popper.js, Microsoft Application Insights, OneTrust Cookie Consent, Google Tag Manager, Microsoft Clarity
Performance
moderate
Mobile
good
Accessibility
good
SEO
basic

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Microsoft Clarity, Google Tag Manager, Microsoft Application Insights
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Microsoft Clarity, Microsoft Application Insights
Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content in Lithuanian language.
  2. Strong corporate branding consistent with Teva Pharmaceutical Industries.
  3. Comprehensive cookie and privacy policies with consent mechanisms.
  4. No direct contact emails or phone numbers found on the homepage or footer.
  5. No explicit security or incident response policies published.
  6. Use of modern analytics and monitoring tools with privacy compliance.
  7. No signs of WAF or content blocking detected.
  8. WHOIS data unavailable due to query limits; domain appears legitimate.
Technical notes

Notes

The website uses a modern JavaScript stack with jQuery, Popper.js, and Microsoft Application Insights for telemetry. It integrates cookie consent via OneTrust and tracking via Google Tag Manager and Microsoft Clarity. The site is mobile-optimized with responsive images and accessible navigation. Performance is moderate, with room for optimization. No CMS is explicitly detected, suggesting a custom or proprietary platform. Hosting details are not disclosed. The site uses canonical URLs and meta tags for SEO but could improve with richer structured data. Overall, the technical implementation supports a professional corporate website with good user experience and compliance features.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with sicor.lt. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review sicor.lt.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.